Common Stock and Stock Options |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock Option Plans | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common Stock and Stock Options | Note 5. Common Stock and Stock Options Stock based compensation cost for all stock awards is based on the grant date fair value and recognized over the required service (vesting) period. Employees received compensation of 8,709 aggregate shares of common stock of the Company during the three months ended March 31, 2024. These shares had an aggregate value of $43,980 and were recorded as non-cash stock compensation expense in the financial statements for the three months ended March 31, 2024. There was $0 stock based compensation expense for the same period in 2025. Note 5. Common Stock and Stock Options (continued) The cumulative status of options granted and outstanding at March 31, 2025 and December 31, 2024, as well as any options which became exercisable in connection with the Company’s stock option plans is summarized as follows: Employee Stock Options
Exercise price for options was $1.25 at March 31, 2025, with a contractual life of 3.1 years. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||